[{"AccountsPayableCurrent_0_Q3_USD":2724000.0,"PaymentsOfStockIssuanceCosts_3_Q3_USD":0.0,"PaymentsOfFinancingCosts_3_Q3_USD":0.0,"PaymentOfFinancingAndStockIssuanceCosts_3_Q3_USD":200000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-1467000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-540000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":38000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_3_Q3_USD":-27000.0,"OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_1_Q3_USD":38000.0,"OtherAssetsNoncurrent_0_Q3_USD":319000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":546000.0,"OperatingIncomeLoss_3_Q3_USD":-63852000.0,"PaymentsToAcquireInvestments_3_Q3_USD":216613000.0,"OperatingIncomeLoss_1_Q3_USD":-24802000.0,"OperatingExpenses_1_Q3_USD":24802000.0,"NonoperatingIncomeExpense_3_Q3_USD":248000.0,"NonoperatingIncomeExpense_1_Q3_USD":100000.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_3_Q3_USD":0.0,"NetIncomeLossAttributableToRedeemableNoncontrollingInterest_1_Q3_USD":0.0,"NetIncomeLoss_3_Q3_USD":-63604000.0,"NetIncomeLoss_1_Q3_USD":-24702000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-48542000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-182912000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":35680000.0,"LongTermInvestments_0_Q3_USD":124636000.0,"OperatingExpenses_3_Q3_USD":63852000.0,"LineOfCredit_0_Q3_USD":400000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":68000.0,"PreferredStockSharesAuthorized_0_Q3_shares":200000000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":43559787.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":43663985.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":193000.0,"StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest_0_Q3_USD":341030000.0,"StockholdersEquity_0_Q3_USD":341030000.0,"ShortTermInvestments_0_Q3_USD":88219000.0,"ShareBasedCompensation_3_Q3_USD":10714000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-116933000.0,"RestrictedCashNoncurrent_0_Q3_USD":371000.0,"RestrictedCashAndInvestmentsCurrent_0_Q3_USD":34308000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":47637000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"ResearchAndDevelopmentExpense_1_Q3_USD":18729000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":291000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":435000.0,"ProfitLoss_3_Q3_USD":-63604000.0,"ProfitLoss_1_Q3_USD":-24702000.0,"ProceedsFromStockPlans_3_Q3_USD":495000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":33769000.0,"ProceedsFromMinorityShareholders_3_Q3_USD":34853000.0,"ProceedsFromIssuanceOfConvertiblePreferredStock_3_Q3_USD":0.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":3176000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"RedeemableNoncontrollingInterestEquityCarryingAmount_0_Q3_USD":35000000.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":43663985.0,"LiabilitiesCurrent_0_Q3_USD":10299000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":71000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-24664000.0,"CommonStockValue_0_Q3_USD":4000.0,"CommonStockSharesOutstanding_0_Q3_shares":43682671.0,"CommonStockSharesIssued_0_Q3_shares":43682671.0,"CommonStockSharesAuthorized_0_Q3_shares":1000000000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"CommitmentsAndContingencies_0_Q3_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-195774000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":169688000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":135009000.0,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-63631000.0,"AssetsCurrent_0_Q3_USD":260712000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":7677795.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":7677795.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":10714000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":4161000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":4161000.0,"AdditionalPaidInCapital_0_Q3_USD":457995000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":-36000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":144000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":134000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":7575000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":-1360000.0,"Assets_0_Q3_USD":386329000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":386329000.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_1_Q3_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_1_Q3_USD":-24664000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":1048000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q3_USD":1079000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFour_0_Q3_USD":1112000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearFive_0_Q3_USD":927000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":806000.0,"LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive_0_Q3_USD":246000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":5289000.0,"InvestmentIncomeInterest_3_Q3_USD":1715000.0,"InvestmentIncomeInterest_1_Q3_USD":640000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":152000.0,"IncreaseDecreaseInAccountsReceivableRelatedParties_3_Q3_USD":0.0,"ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest_3_Q3_USD":0.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_3_Q3_USD":2995000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":6073000.0,"GainLossOnSaleOfPropertyPlantEquipment_3_Q3_USD":-58000.0,"FairValueConcentrationOfRiskInvestments_0_Q3_USD":0.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2862000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.46,"EarningsPerShareDiluted_1_Q3_USD":-0.57,"EarningsPerShareBasic_3_Q3_USD":-1.46,"EarningsPerShareBasic_1_Q3_USD":-0.57,"DepreciationDepletionAndAmortization_3_Q3_USD":87000.0,"DebtSecuritiesAvailableForSaleUnrealizedLossPosition_0_Q3_USD":0.0,"ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest_3_Q3_USD":-63631000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":16215000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":43559787.0,"Ticker":"KNTE","CIK":"1797768","name":"KINNATE BIOPHARMA INC.","OfficialName":"Kinnate Biopharma Inc. Common Stock","form":"10-Q","period":"20210930","fy":"2021.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"393785585.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20211110"}]